| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/15/2011 | US20110224241 Isothiazole and pyrazole derivatives as fungicides |
| 09/15/2011 | US20110224232 Treatment of Pulmonary Fungal Infection With Voriconazole via Inhalation |
| 09/15/2011 | US20110224228 Antifungal agents |
| 09/15/2011 | US20110224225 Inhibitors of protein kinases |
| 09/15/2011 | US20110224208 Novel inhibitors of flavivirus replication |
| 09/15/2011 | US20110224207 Flavivirus inhibitors and methods for their use |
| 09/15/2011 | US20110224206 Triazole compounds that modulate hsp90 activity |
| 09/15/2011 | US20110224203 Benzimidazole derivatives and their use as protein kinase inhibitors |
| 09/15/2011 | US20110224186 Carbacephem beta-lactam antibiotics |
| 09/15/2011 | US20110224182 Salts of (3-0-(3',3'-dimethylsuccinyl) betulinic acid and solid state forms thereof |
| 09/15/2011 | US20110224170 Pyranopyranone derivatives as antimicrobial agents |
| 09/15/2011 | US20110224162 Synthetic analogues of phosphatidyl-myo-inositol mannosides with an inhibitory activity of the inflammatory response |
| 09/15/2011 | US20110224134 Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors |
| 09/15/2011 | US20110224133 Highly Potent Peptides To Control Cancer And Neurodegenerative Diseases |
| 09/15/2011 | US20110224132 Use of the long pentraxin ptx3 for the prevention or treatment of viral diseases |
| 09/15/2011 | US20110224130 Cross-linked glycopeptide-cephalosporin antibiotics |
| 09/15/2011 | US20110224129 Lipopeptide Compounds and Their Use |
| 09/15/2011 | US20110223658 Monoclonal antibodies with enhanced adcc function |
| 09/15/2011 | US20110223266 Beverage and medicament containing bamboo extract as a main ingredient |
| 09/15/2011 | US20110223259 Anti-viral pharmaceutical compositions |
| 09/15/2011 | US20110223249 Extended release compositions comprising mycophenolate sodium and processes thereof |
| 09/15/2011 | US20110223239 Spermicidal and virucidal properties of various forms of sophorolipids |
| 09/15/2011 | US20110223238 Bisbenzamidines for the Treatment of Pneumonia |
| 09/15/2011 | US20110223234 Process for Manufacturing Chewable Dosage Forms for Drug Delivery and Products Thereof |
| 09/15/2011 | US20110223233 Microfabricated nanopore device for sustained release of therapeutic agent |
| 09/15/2011 | US20110223216 Nanoparticles and Porous Particles and Methods of Making the Same |
| 09/15/2011 | US20110223212 Drug eluting superhydrophobic coatings |
| 09/15/2011 | US20110223208 Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations |
| 09/15/2011 | US20110223202 Cationic core-shell peptide nonoparticles |
| 09/15/2011 | US20110223200 Novel compositions and methods |
| 09/15/2011 | US20110223199 METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES |
| 09/15/2011 | US20110223198 dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants |
| 09/15/2011 | US20110223196 Hiv/siv vaccines for the generation of mucosal and systemic immunity |
| 09/15/2011 | US20110223195 Composition comprising chitosan for ocular administration of vaccine(s) to avians |
| 09/15/2011 | US20110223194 Vaccine |
| 09/15/2011 | US20110223193 Method for the preparation of medical devices and devices obtained therefrom |
| 09/15/2011 | US20110223185 Chimeric hepatitis c virus antigens for eliciting an immune response |
| 09/15/2011 | US20110223174 Nontypeable Haemophilus Influenzae Virulence Factors |
| 09/15/2011 | US20110223173 Botulinum Neurotoxin A Receptor and the Use Thereof |
| 09/15/2011 | US20110223163 Monoclonal antibodies that react with the capsule of bacillus anthracis |
| 09/15/2011 | US20110223153 Modified silk films containing glycerol |
| 09/15/2011 | US20110223134 Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases |
| 09/15/2011 | US20110223132 Isothiazoloquinolones and related compounds as anti-infective agents |
| 09/15/2011 | US20110223131 Antiviral compounds |
| 09/15/2011 | US20110223130 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE |
| 09/15/2011 | US20110223105 New 5-aminolevulinic acid prodrugs for use in photodynamic therapy and photodynamic diagnosis |
| 09/15/2011 | US20110220265 Preparation for External Use |
| 09/15/2011 | DE102010006245A1 Herstellung und Verwendung antibakterieller, antiproliferativer und antiphytopathogener Benzanthrine Production and use antibacterial, anti-proliferative and antiphytopathogenic Benzanthrine |
| 09/15/2011 | CA2849668A1 Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses |
| 09/15/2011 | CA2811221A1 Humanized and chimeric anti-properdin antibodies |
| 09/15/2011 | CA2800235A1 Rifaximin ready-to-use suspension |
| 09/15/2011 | CA2795977A1 Method of treatment |
| 09/15/2011 | CA2792691A1 Vaccine |
| 09/15/2011 | CA2792684A1 Crystalline salts of a potent hcv inhibitor |
| 09/15/2011 | CA2792679A1 A novel mucosal vaccination approach for herpes simplex virus type-2 |
| 09/15/2011 | CA2792674A1 Peptide compounds that can be used as antibacterial agents |
| 09/15/2011 | CA2792616A1 Parenteral formulations of macrolide antibiotics |
| 09/15/2011 | CA2792601A1 Solid compositions of amorphous hcv inhibitors |
| 09/15/2011 | CA2792121A1 Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases |
| 09/15/2011 | CA2791946A1 Treatment of streptococcal infections |
| 09/15/2011 | CA2789440A1 Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| 09/14/2011 | EP2365097A1 Nucleic acid probe-based assays for prokaryotic and eukaryotic organisms |
| 09/14/2011 | EP2365082A1 BVDV virus-like particles |
| 09/14/2011 | EP2364982A1 Spiro-piperidine compounds as chemokine receptor antagonists and medicinal use thereof |
| 09/14/2011 | EP2364731A2 Methods of administering anti-TNFalpha antibodies |
| 09/14/2011 | EP2364727A2 Molecular antigen array |
| 09/14/2011 | EP2364726A2 Vaccine against neisseria infection |
| 09/14/2011 | EP2364725A2 Immunization method against neisseria meningitidis serogroups a and c |
| 09/14/2011 | EP2364712A1 Topical cosmetic or pharmaceutical composition comprising probiotic lactobacillus strains and use of same |
| 09/14/2011 | EP2364707A2 Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof |
| 09/14/2011 | EP2364702A2 Kinase inhibitors for preventing or treating pathogen infection and method of use thereof |
| 09/14/2011 | EP2364321A1 Hepatitis c virus inhibitors |
| 09/14/2011 | EP2364314A1 Modulators of toll-like receptors |
| 09/14/2011 | EP2364309A2 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
| 09/14/2011 | EP2364153A1 Chitosan derivatives to treat animals or optimize animal health |
| 09/14/2011 | EP2364139A2 Ngna compositions and methods of use |
| 09/14/2011 | EP2275441A9 High affinity HIV T cell receptors |
| 09/14/2011 | EP1912997B1 Macrocyclic inhibitors of hepatitis c virus |
| 09/14/2011 | EP1901723B9 Antimicrobial materials |
| 09/14/2011 | EP1893211B1 Use of sanglifehrin in hcv |
| 09/14/2011 | EP1890707B1 Nutritional supplement with colostrum and epa and optionally dha or gla |
| 09/14/2011 | EP1799253B1 Multivalent canine vaccines against leptospira bratislava and other pathogens |
| 09/14/2011 | EP1713480B1 The use of quaternary pyridinium salts as vasoprotective agents |
| 09/14/2011 | EP1445264B1 Substance specific to pd-1 |
| 09/14/2011 | EP1377551B1 Antiproliferative agents |
| 09/14/2011 | EP1377314B1 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 09/14/2011 | EP1237582B1 Methods for introducing genes into mammalian subjects |
| 09/14/2011 | CN1965850B Roxithromycin injection and preparation process thereof |
| 09/14/2011 | CN1918172B Rifamycin analogs and uses thereof |
| 09/14/2011 | CN1918146B Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 09/14/2011 | CN1903357B Liver hydrolytic peptide for injection and preparation method therefor |
| 09/14/2011 | CN1802179B Compositions containing piperacillin and tazobactam useful for injection |
| 09/14/2011 | CN1642551B Inhibitors of histone deacetylase |
| 09/14/2011 | CN102186872A Anti-xdr-tb agent, anti-mdr-tb agent, and combined anti-tuberculous agent |
| 09/14/2011 | CN102186850A Phenanthroindolizidine derivative and nfkb inhibitor containing same as active ingredient |
| 09/14/2011 | CN102186849A Phenanthroindolizidine compound and nf?b inhibitor containing same as active ingredient |
| 09/14/2011 | CN102186846A Pyridine derivative having substituted hetero ring and substituted ?-glutamylamino group, and anti-fungal agent comprising same |
| 09/14/2011 | CN102186845A S1p receptors modulators and their use thereof |
| 09/14/2011 | CN102186503A Stable aqueous formulations of water insoluble or poorly soluble drugs |
| 09/14/2011 | CN102186500A Mycobacterium tuberculosis vaccine |